Skip to content
Clinical Trials – home
HungaryBack to Hungary

Clinical trials in Szombathely – page 5

173 clinical trials in Szombathely, Hungary across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Szombathely at a glance
173
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

173 trials in Szombathely

Open in trial search

Arteriosclerosis

Not yet recruiting

Study of olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Olpasiran
  • Sponsor:Amgen Inc.

Rheumatoid arthritis

Not yet recruiting

Study on the Effectiveness and Safety of Tocilizumab and Methotrexate for Adults with Moderate to Severe Rheumatoid Arthritis

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Tocilizumab
  • Sponsor:Dr Reddy's Laboratories Limited

Osteoporosis postmenopausal

Not yet recruiting

Study on the Effects of BP16 and Denosumab in Women with Post-Menopausal Osteoporosis

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Ascorbic Acid
  • Sponsor:Curateq Biologics Private Limited

Dermatitis atopic

Not yet recruiting

Study of LY3454738 for Treating Moderate-to-Severe Atopic Dermatitis in Adults

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:LY3454738
  • Sponsor:Eli Lilly & Co.

Colitis ulcerative+1

Not yet recruiting

Study of ABBV-701 and Risankizumab Combination vs Monotherapy in Adults with Moderately to Severely Active Crohn’s Disease or Ulcerative Colitis

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Risankizumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Colitis ulcerative+1

Not yet recruiting

Study of risankizumab plus anti‑α4β7 integrin antibody versus each alone in adults with moderately to severely active Crohn’s disease or ulcerative colitis

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Risankizumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Sjogren's syndrome

Not yet recruiting

A Phase 2a/b Study of DDY391 to Evaluate Efficacy, Safety and Tolerability in Adults with Sjögren's Disease

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Sponsor:Novartis Pharma AG

A Phase 2 Study of LAD603 in Adults with Systemic Lupus Erythematosus and Active Skin Rash

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:LAD603
  • Sponsor:Almirall S.A.

Prostate cancer

Not yet recruiting

A study of saruparib with radiotherapy and hormone therapy for men with high-risk prostate cancer who have a BRCA gene mutation

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Abiraterone Acetate
  • Sponsor:Astrazeneca AB

Endocrine ophthalmopathy

Not yet recruiting

Study on the Effects of VRDN-003 for Patients with Active Thyroid Eye Disease

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:VRDN-003
  • Sponsor:Viridian Therapeutics Inc.

Pneumonia

Not yet recruiting

Study on CAL02 and Sodium Chloride for Patients with Severe Community-Acquired Bacterial Pneumonia

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Cholesterol
  • Sponsor:Eagle Pharmaceuticals Inc.

Evaluation of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Type 2 Diabetes Patients with High Cardiovascular Risk

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Dulaglutide
  • Sponsor:Eli Lilly & Co.

Other cities in Hungary

The busiest research cities in the country

All 73 cities in Hungary

Clinical research in Szombathely

What the registry says about research in the country

01 Respiratory Medicine

Clinical trials focusing on respiratory conditions, particularly investigating new treatments for asthma and COPD. Studies evaluate innovative therapies including atuliflapon and dupilumab for improving lung function and disease control.

  • Moderate to severe asthma management
  • COPD treatment optimization
  • Lung function preservation

Research aims to enhance therapeutic options for patients with uncontrolled respiratory conditions.

02 Dermatology & Immunology

Innovative research in inflammatory skin conditions and immune-mediated disorders, including studies on atopic dermatitis, plaque psoriasis, and hidradenitis suppurativa.

  • Advanced biologics evaluation
  • Inflammatory disease management
  • Novel therapeutic approaches

Studies focus on developing targeted treatments for chronic inflammatory conditions.

03 Oncology & Hematology

Groundbreaking research in cancer treatment and blood disorders, including studies on breast cancer, lymphoma, and multiple myeloma. Investigations of targeted therapies and combination treatments.

  • Breast cancer therapy
  • Lymphoma treatment
  • Multiple myeloma management

Focus on improving survival rates and treatment outcomes in various cancer types.

04 Gastroenterology

Clinical research examining treatments for inflammatory bowel diseases, including studies on Crohn's Disease and Ulcerative Colitis. Evaluation of combination therapies and novel biological agents.

  • IBD treatment advancement
  • Combination therapy assessment
  • Disease control optimization

Emphasis on improving quality of life for patients with chronic digestive conditions.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.